174 related articles for article (PubMed ID: 16652329)
21. Reply to Crane et al., 'Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir'.
Pedrol E; Deig E
AIDS; 2007 Nov; 21(18):2566. PubMed ID: 18025906
[No Abstract] [Full Text] [Related]
22. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
Taéron C
Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
[No Abstract] [Full Text] [Related]
23. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
Nurutdinova D; Onen NF; Hayes E; Mondy K; Overton ET
Ann Pharmacother; 2008 Nov; 42(11):1581-5. PubMed ID: 18957630
[TBL] [Abstract][Full Text] [Related]
24. Marked elevation of the creatine phosphokinase level in a patient receiving tenofovir.
Shere-Wolfe KD; Verley JR
Clin Infect Dis; 2002 Nov; 35(9):1137. PubMed ID: 12384851
[No Abstract] [Full Text] [Related]
25. Tenofovir and changes in renal function.
Gupta SK
Clin Infect Dis; 2005 Aug; 41(4):570-1; author reply 571. PubMed ID: 16028175
[No Abstract] [Full Text] [Related]
26. Effect of tenofovir on renal glomerular and tubular function.
Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
[TBL] [Abstract][Full Text] [Related]
27. [No comparison with NRTI. Tenofovir is robust against resistance trouble].
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():65. PubMed ID: 12043079
[No Abstract] [Full Text] [Related]
28. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
Malik A; Abraham P; Malik N
J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
[TBL] [Abstract][Full Text] [Related]
29. [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
Warpakowski A
MMW Fortschr Med; 2009 Apr; 151(18):54-5. PubMed ID: 19769077
[No Abstract] [Full Text] [Related]
30. Response to Blaas et al., 'Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases'.
Ranneberg B; Mertenskoetter T; Pearce G
AIDS; 2007 Mar; 21(6):783. PubMed ID: 17413708
[No Abstract] [Full Text] [Related]
31. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
Gupta Samir K
AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
[No Abstract] [Full Text] [Related]
32. Serum creatinine changes in HIV-seropositive patients receiving tenofovir.
El Sahly HM; Teeter L; Zerai T; Andrade RA; Munoz C; Nnabuife C; Hunter R
AIDS; 2006 Mar; 20(5):786-7. PubMed ID: 16514316
[No Abstract] [Full Text] [Related]
33. Renal safety of tenofovir disoproxil fumarate.
Sax PE; Gallant JE; Klotman PE
AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
[TBL] [Abstract][Full Text] [Related]
34. CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.
Kakuda TN; Anderson PL; Becker SL
AIDS; 2004 Dec; 18(18):2442-4. PubMed ID: 15622326
[No Abstract] [Full Text] [Related]
35. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine.
Kirian MA; Higginson RT; Fulco PP
Ann Pharmacother; 2004 Oct; 38(10):1660-3. PubMed ID: 15340130
[TBL] [Abstract][Full Text] [Related]
36. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
[TBL] [Abstract][Full Text] [Related]
37. Adverse events experienced by three children taking tenofovir and didanosine in combination.
Hawkins S; Ball C
HIV Med; 2007 Sep; 8(6):411. PubMed ID: 17661851
[No Abstract] [Full Text] [Related]
38. Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
Jaafar A; Séronie-Vivien S; Malard L; Massip P; Chatelut E; Tack I
AIDS; 2009 Jan; 23(2):257-9. PubMed ID: 19098496
[TBL] [Abstract][Full Text] [Related]
39. [Tenofovir (Viread)].
Sidahora; 2002; (1):20-1. PubMed ID: 12772661
[No Abstract] [Full Text] [Related]
40. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
